Caricamento...

Potent Antipneumococcal Activity of Gemifloxacin Is Associated with Dual Targeting of Gyrase and Topoisomerase IV, an In Vivo Target Preference for Gyrase, and Enhanced Stabilization of Cleavable Complexes In Vitro

We investigated the roles of DNA gyrase and topoisomerase IV in determining the susceptibility of Streptococcus pneumoniae to gemifloxacin, a novel fluoroquinolone which is under development as an antipneumococcal drug. Gemifloxacin displayed potent activity against S. pneumoniae 7785 (MIC, 0.06 μg/...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Heaton, Victoria J., Ambler, Jane E., Fisher, L. Mark
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology 2000
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC101612/
https://ncbi.nlm.nih.gov/pubmed/11036032
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !